Patent · US Active

Modified phage for displaying post-translationally modified proteins and uses thereof

US8754015B2 · kind B2 · utility

1Cited by

1References

1Claims

0Family size

Assignee

University of Rochester · US

Inventors

Stephen Dewhurst · Rochester, US
John Treanor · Fairport, US

Key dates

Filing date	Nov 20, 2007
Grant date	Jun 17, 2014
Priority date	—
Expiry date	Oct 18, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are modified phage comprising a fusion protein located on the surface of the phage wherein the fusion protein comprises a surface protein and a post-translationally modified protein. Also disclosed are methods of making and using modified phage comprising post-translationally modified proteins located on the surface of the phage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.